Treatment of insulin-induced lipoatrophy.
Twenty children with insulin-induced lipoatrophy were successfully treated by injecting the insulin into the lipoatrophic area. In 10 children insulin therapy was replaced by monocomponent insulins, while the other 10 children were treated with the insulins they previously used. It is concluded that both monocomponent and less purified insulins are suitable for treating the complication of insulin therapy when the insulin is injected into the lipoatrophic area.
D000273:Adipose Tissue / Q000473:pathology*; D000293:Adolescent; D001284:Atrophy / Q000139:chemically induced / Q000188:drug therapy; D002648:Child; D003920:Diabetes Mellitus / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology; D005260:Female; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D008297:Male; D012737:Sex Factors
D007328:Insulin; D049528:Insulin, Long-Acting